Range Financial Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Range Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-10,785	Closed	-$365K	–	233
2026 Q2	$365K	Sell	10,785 -252	-2%	-$8.39K	0.1%	169
2026 Q1	$332K	Buy	+11,037	New	+$355K	0.11%	163
2024 Q3	–	Sell	-61,777	Closed	-$1M	–	166
2024 Q2	$1M	Buy	61,777 +5,278	+9%	+$81.3K	0.51%	66
2024 Q1	$797K	Buy	+56,499	New	+$712K	0.41%	81

Other funds holding TEVA

Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return

Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Range Financial Group's TEVA Position: Q3 2026 in Review

Range Financial Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2026, closing a stake of 10,785 shares — an estimated $365K sold.

Range Financial Group first reported a position in TEVA in Q1 2024 and held it in 4 quarters. The position peaked at $1M in Q2 2024. 143 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Range Financial Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2026 after selling out during the quarter.
Range Financial Group sold 10,785 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $365K.
Range Financial Group first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and held it in 4 quarters.
Range Financial Group's Teva Pharmaceutical Industries Limited position peaked at $1M in Q2 2024.
143 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.